B Cell Lymphoma
From the Journals
HSCT or systemic treatment should be offered to HIV+ patients with lymphoma
News
FDA approves selinexor for relapsed/refractory DLBCL
News from the FDA/CDC
FDA gives thumbs up to tazemetostat for follicular lymphoma
From the Journals
New EPOCH for adult patients with Burkitt lymphoma
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Conference Coverage
Adding avadomide shows promise for newly diagnosed DLBCL
From the Journals
Added rituximab was effective in children and adolescents with high-risk B-cell NHL
From the Journals
DLBCL patients at academic centers had significantly better survival
Researchers suggested that academic centers might provide increased access to clinical trials, improved physician expertise, improved treatment...
From the Journals
CAR T-cell therapy effective for r/r B-cell lymphoma of the GI tract
Conference Coverage
Largest meeting on cancer research canceled: AACR
Conference Coverage
HIV free 30 months after stem cell transplant, is the London patient cured?